ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Novartis wants to close its Horsham drug research site in West Sussex, England, as part of a larger review of its global research operations. Pending an employee consultation and government approval, the closure will result in about 371 job losses. According to a Novartis official, most of the positions being eliminated are in respiratory R&D. Novartis plans to relocate respiratory research activities to its site in Cambridge, Mass.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X